Oregon Neurology is excited to offer interested patients access to clinical trials, in addition to standard treatments. Participating in a clinical trial is a unique opportunity to help further medical research and potentially receive new medications before they are available to everyone. Our trials are typically in coordination with pharmaceutical companies and focus on providing access to new treatments or helping research existing therapies.

If you or someone you may know is interested in one of the following trials, please talk with your provider or call our office to speak with our clinical trials coordinator. Amazing things are happening here!


Multiple Sclerosis

Trial: A Phase 3, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.
Principal Investigator: David Clark, DO
Sponsor: EMD Serono Research & Development Institute, Inc.

Click here for more information

Charcot Marie Tooth Disease

Trial: A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Principal Investigator: Michael Balm, MD
Sponsor: Pharnext

Click here for more information

Alzheimer’s Disease

A Phase 3, multi-center, randomized, double-blind, parallel group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligo-mannurarate (GV 971) in treatment of mild to moderate Alzheimer’s disease.
Principal Investigator: Raymond Englander, MD
Sponsor: Shanghai Green Valley Pharmaceutical Co., Ltd.

Click here for more information

Parkinson’s Disease

A non-invasive vibrotactile stimulator whose purpose is to address some of the motor issues associated with Parkinson’s disease.
Principal Investigator: Brittany Farro PAC and Raymond Englander, MD
Sponsor: Synergic Medical Technologies, Inc.

Click here for more information

Pediatric Migraines

Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy® XR in the Prevention of Migraine in Children 6 to 11 Years of Age.
Principal Investigator: Jeffery Frank MD
Sponsor: Upsher-Smith Laboratories, LLC

*Not currently on the clinical trials directory.